---
title: "Top 5 HK Stock Gainers/Losers (>100B) (8.27)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297148384.md"
description: "HANSOH PHARMA(03692) rose 16.01%, with a trading turnover 1.2 Billion HKD, and a year-to-date rose 2.6%. Z.AI(02513) rose 12.62%, with a trading turnover 7.7 Billion HKD, and a year-to-date rose 898.3%. HAITIAN FLAV(03288) fell 11.21%, with a trading turnover 455.2 Million HKD, and a year-to-date fell 6.8%. NCI(01336) fell 4.31%, with a trading turnover 836.8 Million HKD, and a year-to-date fell 9.4%."
datetime: "2026-08-27T08:30:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297148384.md)
  - [en](https://longbridge.com/en/news/297148384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297148384.md)
generator: "portal-rs"
---

# Top 5 HK Stock Gainers/Losers (>100B) (8.27)

Hang Seng Index has fell 0.34%, with a year-to-date fell 0.3%; Hang Seng TECH Index has fell 0.13%, with a year-to-date fell 16.2%.

HANSOH PHARMA(03692) rose 16.01%, with a trading turnover 1.2 Billion HKD, and a year-to-date rose 2.6%.

Z.AI(02513) rose 12.62%, with a trading turnover 7.7 Billion HKD, and a year-to-date rose 898.3%.

HAITIAN FLAV(03288) fell 11.21%, with a trading turnover 455.2 Million HKD, and a year-to-date fell 6.8%.

NCI(01336) fell 4.31%, with a trading turnover 836.8 Million HKD, and a year-to-date fell 9.4%.

### Related Stocks

- [03692.HK](https://longbridge.com/en/quote/03692.HK.md)
- [02513.HK](https://longbridge.com/en/quote/02513.HK.md)
- [06809.HK](https://longbridge.com/en/quote/06809.HK.md)
- [09903.HK](https://longbridge.com/en/quote/09903.HK.md)
- [01888.HK](https://longbridge.com/en/quote/01888.HK.md)
- [03288.HK](https://longbridge.com/en/quote/03288.HK.md)
- [01336.HK](https://longbridge.com/en/quote/01336.HK.md)
- [09987.HK](https://longbridge.com/en/quote/09987.HK.md)
- [01810.HK](https://longbridge.com/en/quote/01810.HK.md)
- [03993.HK](https://longbridge.com/en/quote/03993.HK.md)

## Related News & Research

- [G Sachs: HANSOH PHARMA  Ris-rez Phase III Study Strongly Validated, Safety and Earlier-line Expansion in Focus](https://longbridge.com/en/news/298992599.md)
- [HAITIAN FLAV  Completes Acquisition of All Equity Interests in Amoy Food](https://longbridge.com/en/news/298680857.md)
- [UBS: HANSOH PHARMA  Ris-Rez Study Results in Treating Relapsed Small Cell Lung Cancer Encouraging; Rated Buy](https://longbridge.com/en/news/298887889.md)
- [Hansoh Pharma says Phase 3 ARTEMIS-008 study shows overall survival gain for risvutatug rezetecan in relapsed SCLC](https://longbridge.com/en/news/298817200.md)
- [M Stanley Raises NCI  TP to HKD39.9, Rated Underweight](https://longbridge.com/en/news/298991169.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**